Asterra Labs Products
Asterra Labs will distribute products in Summer 2020
Our portfolio today consists of a line of oral CBD products designed to deliver dependable quality and safety to consumers. We are excited that our product development is moving along, as well as the building on our cGMP facilities. We plan to launch our first round of products through our retail partners in late Summer.
Learn more about our facilities and approach to manufacturing.
Our first wave of products will include:
CBD IR Tablets |
||
| 25 mg | Immediate Release | 10 or 30 tablets |
| 50 mg | Immediate Release | 10 or 30 tablets |
| 100 mg | Immediate Release | 10 or 30 tablets |
CBD ER Tablets |
||
| 100 mg | Extended Release | 10 or 30 tablets |
If you are a retailer or wholesaler and want to talk with us about partnering to distribute our products, please visit our partnering page to submit an inquiry.
Product Pipeline
Asterra Labs is developing additional strengths of its immediate and modified release products. Asterra Labs is also investing in subsequent waves of products containing other cannabinoids and combination of cannabinoids in immediate and extended release presentations.
In addition to products for human consumption, Asterra labs is applying its same standards for rigor and control to a forthcoming line of veterinary products. We believe our pets deserve the same high quality we do.
Current Products
Asterra Labs' first wave of products will include the following:
| Immediate Release | 25 mg | 10 or 30 tablets |
| 50 mg | 10 or 30 tablets | |
| 100 mg | 10 or 30 tablets | |
| Extended Release | 100 mg | 10 or 30 tablets |
Learn more about CBD on the Asterra Blog:
A Beginner’s Guide to CBD
Our friends over at Good Housekeeping have published a helpful beginners guide for CBD. Check it out!